Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21483003

Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 May 20
First author
Lübbert M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lübbert M
      type
      Author
    2. name
      Suciu S
      type
      Author
    3. name
      Baila L
      type
      Author
    4. name
      Rüter BH
      type
      Author
    5. name
      Platzbecker U
      type
      Author
    6. name
      Giagounidis A
      type
      Author
    7. name
      Selleslag D
      type
      Author
    8. name
      Labar B
      type
      Author
    9. name
      Germing U
      type
      Author
    10. name
      Salih HR
      type
      Author
    11. name
      Beeldens F
      type
      Author
    12. name
      Muus P
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lübbert M
      type
      Author
    2. name
      Suciu S
      type
      Author
    3. name
      Baila L
      type
      Author
    4. name
      Rüter BH
      type
      Author
    5. name
      Platzbecker U
      type
      Author
    6. name
      Giagounidis A
      type
      Author
    7. name
      Selleslag D
      type
      Author
    8. name
      Labar B
      type
      Author
    9. name
      Germing U
      type
      Author
    10. name
      Salih HR
      type
      Author
    11. name
      Beeldens F
      type
      Author
    12. name
      Muus P
      type
      Author
    bibliography ids
    1. nci-bib-c780fc3fb9de0583b9a95776
    book metadata
    content sha256
    0688ef2b9f58295a438f826d11587577d47d11ad94aa275d202f457cf2094d9f
    document type
    citation
    dois
    1. 10.1200/JCO.2010.30.9245
    electronic publication date
    display
    2011 Apr 11
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21483003
    immutable id
    pubmed:21483003@0688ef2b9f58295a438f826d11587577d47d11ad94aa275d202f457cf2094d9f
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    15
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1987-96
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21483003
      provenance
      batch id
      a366a1bc8ed89d8d7ca5
      provider
      NCBI PubMed ESummary
      record sha256
      fad23e84872fbb7d98d74971579dc4287dc9b9fc9b6cc62ef5e92e354655d23e
      response sha256
      c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
      retrieved at
      2026-09-09T23:46:40.540025+00:00
      publication date
      display
      2011 May 20
      precision
      day
      year
      2011
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21483003/
      title
      Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group.

      Preserved source evidence · Not medical advice